Navigation Links
A*STAR partners Roche to develop new cancer therapeutics
Date:7/14/2014

SingaporeA*STAR's Bioprocessing Technology Institute (BTI) has entered into an agreement with one of the world's largest pharmaceutical company, Roche, to identify novel drug candidates for the detection and treatment of cancer. The partnership brings together BTI's capabilities in novel antibody discovery and Roche's expertise in developing monoclonal antibody (mAbs) therapeutics, opening up the possibility of improved treatment for cancer, a leading cause of death worldwide.

The collaboration makes use of BTI's discovery of a new mechanism where antibodies can directly target and destroy cancer cells, which has the potential for an entirely new class of cancer treatment. Cancer cells may be distinguished from normal cells by their elevated levels of sugar on the cell surface. The mAbs discovered and generated by BTI are able to recognise these sugar targets and allow more accurate identification of cancer cells as compared to traditional antibodies that only target proteins. mAbs generated by BTI are also unique in having a novel mechanism of action; they cause pores to form on the surface of cancer cells, leading to cell degradation and the eventual death of these diseased cells.

Dr Andre Choo, Principal Scientist at BTI and lead investigator for the project, said, "It is exciting to be able to generate a new class of mAbs that can specifically recognise sugars and lead to rapid death of diseased cells. This opens up new strategies to target and kill cancer cells."

Based on this discovery, scientists from BTI have developed a pipeline of mAbs for major cancers found in Singapore. The partnership with Roche will allow new diagnostic tests and cancer treatments to be developed more quickly and to be brought earlier to patient care. Such treatments could complement and augment existing cancer drugs and result in more effective and safer treatments for cancer patients.

Prof Lam Kong Peng, Executive Director of BTI,
'/>"/>

Contact: Vanessa Loh
vanessa_loh@a-star.edu.sg
Biomedical Sciences Institutes (BMSI)
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
2. Fruit flies light the way for A*STAR scientists to pinpoint genetic changes that spell cancer
3. A*STAR scientists identify potential drug target for inflammatory diseases including cancers
4. Singapore scientists led by A*STARs GIS identify 4 mechanisms that contribute to gastric cancers
5. A*STAR scientists discover switch critical to wound healing
6. A*STAR scientist Alex Matter awarded prestigious Szent-Györgyi Prize for progress in cancer
7. A*STAR scientist wins European Molecular Biology Organization Young Investigator award
8. A*STAR scientists uncover potential drug target to nip cancer in the bud
9. A*STAR scientists bring to light mechanism of drug for infections
10. Women With Older Partners More Often Admitted to Nursing Homes
11. University of Houston Graduate College of Social Work announces partnership with MD Anderson
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A*STAR partners Roche to develop new cancer therapeutics
(Date:11/22/2014)... (PRWEB) November 22, 2014 Forbes ... are pleased to announce that Ashley Lombardo and ... #PayItForward contest. , Ms. Lombardo entered friend Candy ... Innovations. She wrote of how her friend is courageously ... as a single mom. Despite medical bills piling up ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... 22, 2014 Developers and plugin specialist of ... entitled FCPX 3D Model bringing the impossible to FCPX ... users to add obj files to FCPX enabling 3d Model ... the line between professional and armature, FCPX 3D Model is ... Studios allows Final Cut Pro X users to upload and ...
(Date:11/22/2014)... 22, 2014 Wright & Schulte LLC ... lawsuits have been scheduled between October 2016 and ... of Illinois. U.S. District Judge Matthew F. Kennelly, who ... Management Order (CMO) on November 6, 2014 that outlined ... to submit documents and other activities in preparation for ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- A clinical ... anemia has been halted a year early because the ... to manage the disease and reduce the risk of ... conducted at 25 medical centers in the United States ... National Heart, Lung, and Blood Institute (NHLBI). Researchers ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... has been a monumental year for Doug Dawson. Motivation ... QuitCash Challenge, helped the 31-year-old Columbia Heights man quit ... 2,000 Minnesotans, including Doug, attempted to quit tobacco use ... grand prize. , On Thursday, November 19, the day ...
... Lisa Maas, executive director of Californians Allied ... response to an Associated Press/Stanford University poll released today ... for personal injury lawyers to sue health care providers. ... hospitals, community clinics, local governments, dentists and other groups ...
... Calif., Nov. 19 Nordic Naturals is honored to ... Program with its Ultimate Omega(TM) 120 soft gels. By ... will be offered to NFL players. The certification program ... oil without unknowingly consuming banned or prohibited substances or ...
... Nov. 19 Monogram Energy, Inc. ("Monogram") (Pink Sheets: ... of Triad Therapeutics, Inc. ("Triad"), which was effective as ... the Stock Purchase and Recapitalization Agreement, shareholders of Monogram ... exchange for approximately 95% ownership to the Triad shareholders ...
... Reserve University (CWRU) School of Medicine (SOM) has received a ... Based Research Network called The Ohio Research Association for Public ... one of 7 practice-based research networks awarded this year, making ... the country. "With increasing threats to public health and ...
... UCSF ... human equivalent may play a critical role in schizophrenia. , ... (Vocus) November 19, 2009 -- UCSF scientists studying nerve cells in ... critical role in schizophrenia., , ,Scientists have known that the mutated form of the human gene ...
Cached Medicine News:Health News:First-Time Father-to-Be Quits Smoking, Wins $5,000 in The QuitCash Challenge(TM) 2Health News:First-Time Father-to-Be Quits Smoking, Wins $5,000 in The QuitCash Challenge(TM) 3Health News:National Poll Confirms Americans Support Curbs on Malpractice Lawsuits 2Health News:Nordic Naturals Ultimate Omega(TM) First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program 2Health News:Monogram Energy, Inc. Acquires Triad Therapeutics, Inc. 2Health News:Case Western School of Medicine receives RWJF grant to establish a public health research network 2Health News:Case Western School of Medicine receives RWJF grant to establish a public health research network 3Health News:Schizophrenia Gene's Role May Be Broader, More Potent, than Thought 2Health News:Schizophrenia Gene's Role May Be Broader, More Potent, than Thought 3Health News:Schizophrenia Gene's Role May Be Broader, More Potent, than Thought 4
(Date:11/21/2014)... and VIENNA, Va. , ... in-home care provider that operates in Southern ... leading provider of remote caregiving technology. Alta will be ... existing client receiving homecare services. Logo - ... technology is the key to providing the kind of ...
(Date:11/21/2014)... Ill. , Nov. 21, 2014  Heated dialogue ... drug prices – from cancer treatments to Gilead,s new ... pharmaceutical leaders around the world questioning what it means ... of care. And while drug pricing ... pharmaceutical industry – from both a general business and ...
(Date:11/21/2014)... MELVILLE, N.Y. , Nov. 21, 2014  Cardinal ... the world,s largest health care services companies, and Henry ... largest provider of health care products and services to ... that the companies have entered into a long-term strategic ... and product offerings to office-based medical practices.  This strategic ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Ident-A-Drug gives you quick accurate identification of oral tablets and capsules used in North America....
... with the latest in scientific clinical trial ... and knowledge resources from CenterWatch. This highly ... you monitor and stay abreast of medical ... in Clinical Trials, Clinical Trial Results, Newly ...
Providing patients and their advocates with a variety of information services and educational materials on clinical research....
Medicine Products: